High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event. (Q54334587)
Jump to navigation
Jump to search
scientific article published on 8 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event. |
scientific article published on 8 December 2011 |
Statements
High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event. (English)
Thomas Knösel
Yuan Chen
Annelore Altendorf-Hofmann
Christine Danielczok
Martin Freesmeyer
Utz Settmacher
Christine Wurst
Lin Lin Yang
Iver Petersen
8 December 2011
138
3
397-403
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference